Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof

Isoxazole/isoxazoline/combretastatin linked dihydroquinazolinone hybrids as potential anticancer agents and process for the preparation thereof

US Patent 8883809 · Granted Nov 11, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PqsR inverse agonists2024
(E)-4-(4-acrylamidophenoxy)-N-methylpicolinamide conjugates as potential antican2021
4β-amidotriazole linked podophyllotoxin derivatives as potential anticancer agen2021
N-((1-phenyl-9H-pyrido[3,4-b]indol-3-yl)methyl)cinnamamides as potential antican2019
(Z)-3,4,5-trimethoxystyrylbenzenesulfonamides as potential anticancer agents2019
Synthesis of new benzothiazole derivatives as potential anti-tubercular agents2018
Pyrazole linked benzimidazole conjugates and a process for preparation thereof2018
N-((3,4,5-trimethoxystyryl)aryl)cinnamamide compounds as potential anticancer ag2018
3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation th2017
Pyrazolochalcones as potential anticancer agents2017
N-((1-benzyl-1H-1,2,3-triazol-4-yl)methyl)arylamide compounds as potential antic2016
Synthesis of new benzothiazole derivatives as potential anti-tubercular agents2016